Subcutaneous mosunetuzumab replaced the IV infusion for patients with R/R LBCL; 57.5% had mostly mild injection-site ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...
Eli Lilly is betting on a pediatric expansion to give it’s IL-23p19 inhibitor Omvoh an edge in the fiercely competitive ...
Many children with PI need regular infusions of immunoglobulin, and SCIg infusions at home have become a common way to get it ...
Although rare, Dr. Sohaib Imtiaz — Chief Medical Officer at People Inc. — explains how someone can survive a lethal injection ...
New Phase 1 data highlight flexibility of injection site for ribupatide injection - Four additional oral presentations from Hengrui Pharma add to the clinical evidence behind Kailera's pipeline ...
Morning Overview on MSN
An injection cut visceral fat 12.01% in a trial where the placebo group gained it
Caliway Biopharmaceuticals reported that its experimental fat-cell injection, CBL-514, reduced visceral fat volume by an ...
I know there are injections. But aren't they expensive?”This is a common response in the exam room when I talk about prevention. Sometimes people feel awkward asking about the price, and the topic ...
Headaches when the weather is bad, knowing when it's going to rain, always feeling unwell when a typhoon approaches... I ...
The SURVIVE trial of the targeted vaccine SurVaxM did not meet its primary OS end point due to longer-than-expected survival ...
Some six years after scoring an initial FDA nod in neuromyelitis optica spectrum disorder, Roche’s IL-6 receptor agonist ...
CBN sleep aid claims are everywhere, but new research links repeated use to dependence. Here's what the sleep trials and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results